Cancer Flashcards
what are the 2 types of genes that control cell division?
tumour suppressor genes
proto oncogene
How does a mutation in tumour suppressor genes cause cancer?
tumour suppressor gene can become inactivates if a mutation occurs
when functioning normally tumour suppressor genes slow cell division by producing proteins that stop cells from dividing or cause them to self destruct (apoptosis)
if mutation occurs, protein isn’t produced so cells able to divide uncontrollably and tumour formed
how does a mutation of a proto-oncogene cause cancer
effect of proto-oncogene e can be increased if mutation occurs in DNA sequence
mutated proto-oncogene is called an oncogene
when functioning normally, proto-oncogenes stimulate cell division by producing proteins that make them divide
if mutation occurs in a proto-oncogene, the gene can be over-active, increasing rate of division, resulting in a tumour
difference between benign and malignant
-malignant are cancerous, grow rapidly and destroy surrounding tissue, cells are not localised and can break off tumours and spread to other parts of body via bloodstream or lymphatic system (metastasis)
-benign tumours are not cancerous, glow slower, covered by fibrous tissue and encapsulated, localised cells, don’t invade other tissues, may put pressure on organs
what does abnormal methylation cause
tumour growth
hypermethylatiom
e.g. tumour suppressor genes are hypermethylated, genes are not transcribed, so proteins to slow cell division are not produced, cells continue to divide uncontrollably, tumour forms
hypomethylation
e.g hypomethylation of proto-oncogenes causing them to act as oncogenes, increases production of protein that encourage cell division, cells divide uncontrollably, forms tumours
effect of increased oestrogen
oestrogen can stimulate cells to divide, more cell divisions increase the change of a mutation, so increases chance of cell becoming cancerous
if cells do become cancerous, rapid replication can be stimulated further by oestrogen
oestrogen is also able to introduce mutations directly into the dna of breast cells